Doseloop Beta

Ephedrine

medication Under review

Ephedrine is a sympathomimetic alkaloid derived from the Ephedra plant, commonly used as a stimulant in supplements for weight management and performance enhancement. It acts primarily by stimulating the release of norepinephrine from nerve terminals and inhibiting its reuptake, which activates alpha and beta adrenergic receptors. This leads to increased heart rate, vasoconstriction, bronchodilation, and central nervous system stimulation, promoting alertness and metabolic rate elevation. In general health applications, ephedrine has been employed to support short-term weight loss by suppressing appetite and enhancing thermogenesis, as well as to improve athletic performance through boosted energy and endurance. Its effects mimic those of epinephrine but with a longer duration, influencing cardiovascular function, lipid metabolism, and fat oxidation in the body.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence from randomized controlled trials and meta-analyses indicates that ephedrine promotes modest short-term weight loss of about 0.9 to 2 kg more than placebo over 4 to 24 weeks, alongside improvements in lipid profiles and reductions in body mass index and waist circumference. Studies in overweight or obese individuals show consistent benefits for weight reduction, with dose-dependent effects up to 150 mg daily, though long-term data beyond several months are lacking. Safety profiles reveal increased heart rate but no significant changes in blood pressure or serious adverse events in controlled settings with healthy or overweight participants. Research consensus supports efficacy for weight loss in supervised use, but emphasizes monitoring due to stimulant effects and potential for mild autonomic symptoms.

Reported Benefits

Reported Side Effects

Research (4 studies)

Meta-Analysis

Efficacy and safety of ephedra-containing oral medications: a systematic review, meta-analysis, and exploratory dose-response analysis for weight reduction.

Frontiers in Pharmacology • 2024

Not specified in abstract

Meta-Analysis

Effects of Ephedrine-Containing Products on Weight Loss and Lipid Profiles: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Frontiers in Pharmacology • 2021 • n=534

Not specified in abstract

Systematic Review

Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.

Office of Dietary Supplements, NIH • 2004

RAND Corporation

Systematic Review

Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance.

Virginia Tech • 2003

Not specified

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 4
Researched benefits 4
Side effects noted 3